Literature DB >> 14646641

Hepatitis B virus infection risk factors and immunity among sexually transmitted disease clinic clients.

Mary Jo Trepka1, Joanna S Weisbord, Guoyan Zhang, Toye Brewer.   

Abstract

BACKGROUND AND OBJECTIVES: Hepatitis B virus (HBV) infection is a sexually transmitted infection that can be prevented with hepatitis B vaccination. GOAL: The goal was to determine prevalence and risk factors for HBV infection and immunity among sexually transmitted disease (STD) clinic clients. STUDY
DESIGN: In this cross-sectional study, consenting adult STD clinic clients were interviewed regarding HBV risk factors and vaccination history, and blood was drawn for HBV serologic testing.
RESULTS: Of the 682 participants, 154 (22.6%) had antibody to hepatitis B core antigen, indicating previous infection, and 64 (9.4%) had only antibody to hepatitis B surface antigen, indicating immunity as a result of hepatitis B vaccination. Only 130 (19.1%) of all participants reported receiving at least one dose of hepatitis B vaccine.
CONCLUSION: The majority of clients were susceptible to HBV, were at high risk for HBV infection, and would benefit from hepatitis B vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646641     DOI: 10.1097/01.OLQ.0000091126.08640.FC

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs.

Authors:  Temitope Foster; Huiming Hon; Fasiha Kanwal; Steven Han; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

2.  A cross-sectional analysis of acute hepatitis B virus reported to the Vancouver Coastal Health Authority from 2000 to 2003.

Authors:  Yvette Leung; Jessica Ip Chan; Eric Yoshida; Hong-Xing Wu; Patricia C Daly
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

3.  The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.

Authors:  Deepika L Koya; Elizabeth G Hill; Paul M Darden
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.